about
Erythropoiesis-stimulating agents for myelodysplastic syndromesErythropoiesis-stimulating agents for myelodysplastic syndromesErythropoietin or Darbepoetin for patients with cancer - meta-analysis based on individual patient dataEstimating the mean and variance from the median, range, and the size of a sampleThe use of recombinant erythropoietin for the treatment of chemotherapy-induced anemia in patients with ovarian cancer does not affect progression-free or overall survival.Effect of treatment with epoetin beta on short-term tumour progression and survival in anaemic patients with cancer: A meta-analysisEpoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial.Recombinant human epoetin beta in the treatment of chemotherapy-related anemia.Pharmacovigilance in practice: erythropoiesis-stimulating agents.Does access to clinical study reports from the European Medicines Agency reduce reporting biases? A systematic review and meta-analysis of randomized controlled trials on the effect of erythropoiesis-stimulating agents in cancer patients.
P2860
Q24186244-3FBD548B-B619-457A-B0CB-BF57571C3203Q24202526-F951B691-F614-40F9-9214-FFDDD547468CQ24240202-E9ED264E-E358-479D-AFF8-5A7317BC10FBQ24801782-D6C757AC-EA2A-494E-9FE3-94ADBD3EC5BDQ30453014-3685F985-4432-40ED-A66D-B20CF26DAFA8Q36612465-1839A05A-1E85-4D6B-9B13-B045A6207228Q36614017-62E60E54-58C4-497B-A5DE-C3E778CEFD9CQ37230276-C038795B-E113-4E20-B3AF-710EDE21E22CQ38217083-542B5376-861A-4D55-AFCD-474E6AD05F65Q47140896-2210DD21-9A34-4CB2-9243-003EFD1DB64B
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Erythropoietin for patients with malignant disease
@ast
Erythropoietin for patients with malignant disease
@en
Erythropoietin for patients with malignant disease
@en-gb
Erythropoietin for patients with malignant disease
@nl
type
label
Erythropoietin for patients with malignant disease
@ast
Erythropoietin for patients with malignant disease
@en
Erythropoietin for patients with malignant disease
@en-gb
Erythropoietin for patients with malignant disease
@nl
prefLabel
Erythropoietin for patients with malignant disease
@ast
Erythropoietin for patients with malignant disease
@en
Erythropoietin for patients with malignant disease
@en-gb
Erythropoietin for patients with malignant disease
@nl
P2093
P1476
Erythropoietin for patients with malignant disease
@en
P2093
G Schwarzer
J Seidenfeld
S Langensiepen
P356
10.1002/14651858.CD003407.PUB2
P577
2004-07-19T00:00:00Z